Faith Abodunrin MD (@your_hemoncdoc) 's Twitter Profile
Faith Abodunrin MD

@your_hemoncdoc

Nigerian girl🇳🇬 || Med School in Hungary @UniDeb ||
Hematology and Oncology fellow @UCHemOncFellows via @IMCreighton.
Clinical researcher. #GlobalOncology

ID: 1397228277731893257

linkhttps://www.researchgate.net/profile/Faith-Abodunrin calendar_today25-05-2021 16:29:24

302 Tweet

733 Followers

598 Following

University of Chicago Hem/Onc Fellows (@uchemoncfellows) 's Twitter Profile Photo

We are proud of our fellows who are recipients of this year's Conquer Cancer grants/awards. Congratulations to Dr. Alexandra Rojek, Dr. Daniel Peiffer, Dr. Joseph Cannova, and Dr. Wenji Guo for their ASCO YIAs. Congrats to Dr. Faith Abodunrin on the ASCO merit award! #ASCO25

Fionnuala Crowley (@fionnualacrowle) 's Twitter Profile Photo

If you’re a trainee or early career oncologist at #ASCO25 the ASCO TECAG lounge in Hall C is your home- breakfast, chargers, free swag, cosy couches, mentoring sessions, career advice- we have it all!

If you’re a trainee or early career oncologist at #ASCO25 the <a href="/ASCOTECAG/">ASCO TECAG</a> lounge in Hall C is your home- breakfast, chargers, free swag, cosy couches, mentoring sessions, career advice- we have it all!
Abner Antonio Murray, MD PhD (@dominicandoc2) 's Twitter Profile Photo

🚨 Final data from the ARROW study just dropped at #ASCO25! gilberto lopes Stephen V Liu, MD Pralsetinib continues to show durable benefit in advanced RET fusion–positive NSCLC across both treatment-naïve and pretreated groups 👇 🧬 ORR: 🔹 81% (treatment-naïve, post-eligibility

Chinmay Jani (@jani_chinmay) 's Twitter Profile Photo

Excited to join the GRACE team as an ambassador alongside Arthur Aung and Faith Abodunrin MD! Looking forward to contributing to #patient #education and empowering through knowledge.

Excited to join the <a href="/cancerGRACE/">GRACE</a> team as an ambassador alongside <a href="/Arthur_Aung/">Arthur Aung</a> and <a href="/your_hemoncdoc/">Faith Abodunrin MD</a>! Looking forward to contributing to #patient #education and empowering through knowledge.
UChicagoCancerCenter (@uccancercenter) 's Twitter Profile Photo

In a case-based panel, Ben Derman, MD, joined other panelists, Neha Korde,MD, Luciano Costa, MD, PhD, and Rebecca Silberman, MD, to discuss the best strategies to incorporate MRD into the treatment of MM patients. Luciano J Costa Ben Derman University of Chicago Hematology/Oncology

In a case-based panel, Ben Derman, MD, joined other panelists, Neha Korde,MD, Luciano Costa, MD, PhD, and Rebecca Silberman, MD, to discuss the best strategies to incorporate MRD into the treatment of MM patients. <a href="/End_myeloma/">Luciano J Costa</a> <a href="/bdermanmd/">Ben Derman</a> <a href="/UChicagoHemOnc/">University of Chicago Hematology/Oncology</a>
Shreyas Kalantri, MD (@kalantrishreyas) 's Twitter Profile Photo

📣 NIVOPOSTOP at #ASCO25: Adjuvant nivolumab after CRT improves DFS in resected high-risk LA HNSCC. 🔹 3-yr DFS: ▪️ NIVO + CRT: 63.1% ▪️ CRT alone: 52.5% 🔹 HR 0.76 (95% CI: 0.60–0.98), p = 0.034 🔹 Grade 4 AEs: ↓ with CRT alone, but <2% in both arms long-term

📣 NIVOPOSTOP at #ASCO25:
Adjuvant nivolumab after CRT improves DFS in resected high-risk LA HNSCC.

🔹 3-yr DFS:
▪️ NIVO + CRT: 63.1%
▪️ CRT alone: 52.5%
🔹 HR 0.76 (95% CI: 0.60–0.98), p = 0.034
🔹 Grade 4 AEs: ↓ with CRT alone, but &lt;2% in both arms long-term
Faith Abodunrin MD (@your_hemoncdoc) 's Twitter Profile Photo

The highlight of my day 3 at #ASCO25 was facilitating a round table discussion on making the most of oncology fellowship. Thank you for the opportunity to share with trainees. ASCO TECAG

The highlight of my day 3 at #ASCO25 was facilitating a round table discussion on making the most of oncology fellowship. Thank you for the opportunity to share with trainees. <a href="/ASCOTECAG/">ASCO TECAG</a>
UChicagoCancerCenter (@uccancercenter) 's Twitter Profile Photo

At #ASCO25, Faith Abodunrin, MD (Faith Abodunrin MD) presented a poster showing promising findings on functional and survival outcomes in HPV-positive oropharyngeal cancer with response-adaptive radiation de-escalation strategy. UChicagoOHNS Ari Rosenberg University of Chicago Hematology/Oncology

Oyepeju Abioye-Akintola, MD, MSc (@abioyeoyepejumd) 's Twitter Profile Photo

One of my favorite things from #ASCO25: Connecting with so many Nigerians and basking in our shared heritage. Couldn't be prouder of all the present & future accomplishments ✨️✨️

One of my favorite things from #ASCO25: Connecting with so many Nigerians and basking in our shared heritage. 

Couldn't be prouder of all the present &amp; future accomplishments ✨️✨️